Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;84(3):471-485.
doi: 10.1007/s00280-019-03884-5. Epub 2019 Jun 18.

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review

Marie Lindhard Madsen  1 , Hanne Due  1   2 , Niels Ejskjær  2   3 , Paw Jensen  1   4 , Jakob Madsen  1 , Karen Dybkær  5   6   7
Affiliations

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review

Marie Lindhard Madsen et al. Cancer Chemother Pharmacol. 2019 Sep.

Abstract

Purpose: Vincristine is widely used as anticancer therapy for a variety of hematological malignancies. The treatment is limited by progressive vincristine-induced neuropathy, possibly including both peripheral sensory and motor nerves, autonomic nervous functions, and the central nervous system. This dose-limiting side-effect can diminish quality of life and, furthermore, cause discontinuation of vincristine treatment. The present review elucidates the current knowledge regarding vincristine-induced neuropathy in hematologic malignancies, focusing on neuropathy assessment, clinical and molecular predictive markers, drug-drug interference, prevention, and treatment.

Methods: This review is conducted by a systematic search strategy for the identification of relevant literature in the PubMed and Embase databases.

Results: No clinical parameters displayed convincing potential as predictors of vincristine-induced neuropathy; however, preexisting neuropathy was consistently reported to be associated with an increased risk of neurotoxicity. In contrast, molecular markers, including polymorphisms in genes involved in the pharmacodynamics and pharmacokinetics of vincristine, displayed great potential as predictive markers of neuropathy incidence and severity. Furthermore, antifungal drugs, such as itraconazole and voriconazole, decrease the metabolism of vincristine and consequently lead to severe neuropathy when co-administered with vincristine, underscoring why fluconazole should be the antifungal drug of choice.

Conclusion: Reports from the 71 included studies clearly emphasize the lack of consistency in neuropathy assessment, grading systems, and reporting, making it difficult to interpret results between studies. Thus, truer clinical and molecular markers could emerge if the consistency of neuropathy detection and reporting increases by the use of conventional standardized neuropathy assessment tools and grading scales.

Keywords: Biomarkers; Hematologic malignancies; Neurotoxicity; Vincristine; Vincristine-induced neuropathy.

PubMed Disclaimer

Conflict of interest statement

Author M.L.M declares that she has no conflict of interest. Author H.D declares that she has no conflict of interest. Author N.E declares that he has no conflict of interest. Author P.J declares that he has no conflict of interest. Author J.M declares that he has no conflict of interest. Author K.D declares that she has no conflict of interest.

References

    1. Yang L, Yu L, Chen X, Hu Y, Wang B. Clinical analysis of adverse drug reactions between vincristine and triazoles in children with acute lymphoblastic leukemia. Med Sci Monit. 2015;21:1656–1661. - PMC - PubMed
    1. Gidding CE, Kellie SJ, Kamps WA, de Graaf SS. Vincristine revisited. Crit Rev Oncol Hematol. 1999;29(3):267–287. - PubMed
    1. Correia JJ. Effects of antimitotic agents on tubulin–nucleotide interactions. Pharmacol Ther. 1991;52(2):127–147. - PubMed
    1. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell. 2008;14(2):111–122. - PubMed
    1. Gutierrez-Camino A, Umerez M, Martin-Guerrero I, Garcia de Andoin N, Santos B, Sastre A, Echebarria-Barona A, Astigarraga I, Navajas A, Garcia-Orad A. Mir-pharmacogenetics of vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia. Pharmacogenom J. 2017 - PubMed

Publication types

MeSH terms

Substances